BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

5:23 PM
 | 
Nov 02, 2009
 |  BC Extra  |  Company News

Amylin, Takeda in obesity deal

Amylin Pharmaceuticals Inc. (NASDAQ:AMLN) partnered with Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) to co-develop and commercialize therapeutics for obesity and related indications. Amylin will receive $75 million up front and is eligible to receive...

Read the full 152 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >